Sickle cell anemia with moyamoya disease: Outcomes after EDAS procedure

Pediatric Neurology

Volumn 29, Issue 2, 2003, Pages 124-130

  Fryer, Robert H ^a,c   Anderson, Richard C ^a   Chiriboga, Claudia A ^a,b   Feldstein, Neil A ^a  

^a Columbia University ^*  (United States)

^b HARLEM HOSPITAL CENTER   (United States)

^c NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANASTOMOSIS; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN BLOOD VESSEL; CEREBROVASCULAR ACCIDENT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENCEPHALODUROARTERIOSYNANGIOSIS PROCEDURE; FEMALE; FOLLOW UP; HUMAN; MALE; MOYAMOYA DISEASE; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVASCULARIZATION; SEIZURE; SICKLE CELL ANEMIA; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; VASCULAR SURGERY;

EID: 0042251747     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(03)00047-X     Document Type: Article

References (54)

1. Ohene-Frempong K., Weiner S.J., Sleeper L.A., et al. Cerebrovascular accidents in sickle cell disease Rates and risk factors . Blood. 91:1998;288-294.
2. Powars D., Imbus C. Cerebral vascular accidents in sickle cell anemia. Tex Rep Biol Med. 40:1980;293-304.
3. Pavlakis S.G., Prohovnik I., Piomelli S., DeVivo D.C. Neurologic complications of sickle cell disease. Adv Pediatr. 36:1989;247-276.
4. Drew J.M., Scott J.A., Chua G.T. General case of the day. Moyamoya disease in a child with sickle cell disease. Radiographics. 13:1993;483-484.
5. Stockman J.A., Nigro M.A., Mishkin M.M., Oski F.A. Occlusion of large cerebral vessels in sickle-cell anemia. N Engl J Med. 287:1972;846-849.
6. Merkel K.H., Ginsberg P.L., Parker J.C. Jr, Post M.J. Cerebrovascular disease in sickle cell anemia A clinical, pathological and radiological correlation . Stroke. 9:1978;45-52.
7. Garza-Mercado R. Pseudomoyamoya in sickle cell anemia. Surg Neurol. 18:(6):1982;425-431.
8. Ramsewak W., Gill G., Lo R. Moyamoya in sickle cell disease demonstrated by DSA and Hexabrix. J Can Assoc Radiol. 36:1985;332-333.
9. Mendelowitsch A., Sekhar L.N., Clemente R., Shuaib A. EC-IC bypass improves chronic ischemia in a patient with moyamoya disease secondary to sickle cell disease An in vivo microdialysis study . Neurol Res. 19:1997;66-70.
10. Fukui M. Current state of study on moyamoya disease in Japan. Surg Neurol. 47:1997;138-143.
11. Chaudari K., Edwards R. Adult moyamoya disease. BMJ. 307:1993;852-854.
12. Numaguchi Y., Balsys R., Marc J.A., O'Brien M.S. Some observations in progressive arterial occlusions in children and young adolescents (Moyamoya disease) . Surg Neurol. 6:1976;293-300.
13. Solomon G.E., Hilal S.K., Gold A.P., Carter S. Natural history of acute hemiplegia of childhood. Brain. 93:1970;107-120.
14. Suzuki J., Takaku A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 20:1969;288-299.
15. Levine S.R., Fagan S.C., Pessin M.S., et al. Accelerated intracranial occlusive disease, oral contraceptives, and cigarette use. Neurology. 41:1991;1893-1901.
16. Poor G., Gacs G. The so-called 'moyamoya disease'. J Neurol Neurosurg Psychiatry. 37:1974;370-377.
17. Cohen N., Berant M., Simon J. Moyamoya and Fanconi's anemia. Pediatrics. 65:1980;804-805.
18. Vernet O., Montes J.L., O'Gorman A.M., Baruchel S., Farmer J.P. Encephaloduroarterio-synangiosis in a child with sickle cell anemia and moyamoya disease. Pediatr Neurol. 14:1996;226-230.
19. Gordon N., Isler W. Childhood moyamoya disease. Dev Med Child Neurol. 31:1989;103-107.
20. Goldstein E.M., Singer H.S. Moyamoya-like disease in Down's syndrome. Pediatr Neurosurg. 16:1990;14-16.
21. Dai A.I., Shaikh Z.A., Cohen M.E. Early-onset Moyamoya syndrome in a patient with Down syndrome Case report and review of the literature . J Child Neurol. 15:2000;696-699.
22. Adams R.J., McKie V.C., Hsu L., et al. Prevention of first stroke by transfusion in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography. N Engl J Med. 339:1998;5-11.
23. Pegelow C.H., Adams R.J., McKie V., et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 126:1995;896-899.
24. Sarnaik S., Soorya D., Kim J., Ravindranath Y., Lusher J. Periodic transfusions for sickle cell anemia and CNS infarction. Am J Dis Child. 133:1979;1254-1257.
25. Cohen A.R., Martin M.B., Silber J.H., Kim H.C., Ohene-Frempong K., Schwartz E. A modified transfusion program for prevention of stroke in sickle cell disease. Blood. 79:1992;1657-1661.
26. Wilimas J., Goff J.R., Anderson H.R. Jr, Langston J.W., Thompson E. Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents. J Pediatr. 96:1980;205-208.
27. Ueki K., Meyer F.B., Mellinger J.F. Moyamoya disease The disorder and surgical treatment . Mayo Clin Proc. 69:1994;749-757.
28. Ikezaki K., Matsushima T., Kuwabara Y., Suzuki S.O., Nomura T., Fukui M. Cerebral circulation and oxygen metabolism in childhood moyamoya disease A perioperative positron emission tomography study . J Neurosurg. 81:1994;843-850.
29. Matsushima Y., Fukai N., Tanaka K., et al. A new surgical treatment of moyamoya disease in children A preliminary report . Surg Neurol. 15:1981;313-320.
30. Matsushima Y., Aoyagi M., Fukai N., Tanaka K., Tsuruoka S., Inaba Y. Angiographic demonstration of cerebral revascularization after encephalo-duro-arterio-synangiosis (EDAS) performed on pediatric moyamoya patients. Bull Tokyo Med Dent Univ. 29:1982;7-17.
31. Tagawa T., Naritomi H., Mimaki T., Yabuuchi H., Sawada T. Regional cerebral blood flow, clinical manifestations, and age in children with moyamoya disease. Stroke. 18:1987;906-910.
32. Soriano S.G., Sethna N.F., Scott R.M. Anesthetic management of children with moyamoya disease. Anesth Analg. 77:1993;1066-1070.
33. Goto Y., Yonekawa Y. Worldwide distribution of moyamoya disease. Neurol Med Chir (Tokyo). 32:1992;883-886.
34. Ikezaki K. Rational approach to treatment of moyamoya disease in childhood. J Child Neurol. 15:2000;350-356.
35. Houkin K., Yoshimoto T., Kuroda S., Ishikawa T., Takahashi A., Abe H. Angiographic analysis of moyamoya disease-how does moyamoya disease progress? Neurol Med Chir (Tokyo). 36:1996;783-787 ; discussion 788.
36. Prohovnik I., Pavlakis S.G., Piomelli S., et al. Cerebral hyperemia, stroke, and transfusion in sickle cell disease. Neurology. 39:1989;344-348.
37. Ferrera P.C., Curran C.B., Swanson H. Etiology of pediatric ischemic stroke. Am J Emerg Med. 15:1997;671-679.
38. Nakashima H., Meguro T., Kawada S., Hirotsune N., Ohmoto T. Long-term results of surgically treated moyamoya disease. Clin Neurol Neurosurg. 99:(Suppl. 2):1997;S156-S161.
39. Kuwabara Y., Ichiya Y., Sasaki M., et al. Cerebral hemodynamics and metabolism in moyamoya disease - a positron emission tomography study. Clin Neurol Neurosurg. 99:(Suppl. 2):1997;S74-S78.
40. Takeuchi S., Ishii R., Tsuchida T., Tanaka R., Kobayashi K., Ito J. Cerebral hemodynamics in patients with moyamoya disease. A study of the epicerebral microcirculation by fluorescein angiography. Surg Neurol. 21:1984;333-340.
41. Takeuchi S., Tanaka R., Ishii R., Tsuchida T., Kobayashi K., Arai H. Cerebral hemodynamics in patients with moyamoya disease. A study of regional cerebral blood flow by the 133Xe inhalation method. Surg Neurol. 23:1985;468-474.
42. Matsushima Y., Aoyagi M., Koumo Y., et al. Effects of encephalo-duro-arterio-synangiosis on childhood moyamoya patients - swift disappearance of ischemic attacks and maintenance of mental capacity. Neurol Med Chir (Tokyo). 31:1991;708-714.
43. Matsushima Y., Inaba Y. Moyamoya disease in children and its surgical treatment. Introduction of a new surgical procedure and its follow-up angiograms. Childs Brain. 11:1984;155-170.
44. Matsushima Y., Aoyagi M., Nariai T., Takada Y., Hirakawa K. Long-term intelligence outcome of post-encephalo-duro-arterio-synangiosis childhood moyamoya patients. Clin Neurol Neurosurg. 99:(Suppl. 2):1997;S147-S150.
45. Adelson P.D., Scott R.M. Pial synangiosis for moyamoya disease in children. Pediatr Neurosurg. 23:1995;26-33.
46. Fujita K., Tamaki N., Matsumoto S. Surgical treatment of moyamoya disease in children Which is more effective procedure, EDAS or EMS? Childs Nerv Syst. 2:1986;134-138.
47. Karasawa J., Touho H., Ohnishi H., Miyamoto S., Kikuchi H. Long-term monitoring study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease. J Neurosurg. 77:1992;84-89.
48. Miyamoto S., Kikuchi H., Karasawa J., Nagata I., Yamazoe N., Akiyama Y. Pitfalls in the surgical treatment of moyamoya disease. Operative techniques for refractory cases. J Neurosurg. 68:1988;537-543.
49. Matsushima T., Inoue T., Suzuki S.O., Fujii K., Fukui M., Hasuo K. Surgical treatment of moyamoya disease in pediatric patients: Comparison between the results of indirect and direct revascularization procedures. Neurosurgery. 31:1992;401-405.
50. Golby A.J., Marks M.P., Thompson R.C., Steinberg G.K. Direct and combined revascularization in pediatric moyamoya disease. Neurosurgery. 45:1999;50-58 ; discussion 58-60.
51. Ikezaki K., Fukui M., Inamura T., Kinukawa N., Wakai K., Ono Y. The current status of the treatment for hemorrhagic type moyamoya disease based on a 1995 nationwide survey in Japan. Clin Neurol Neurosurg. 99:(Suppl. 2):1997;S183-S186.
52. Farrugia M., Howlett D.C., Saks A.M. Moyamoya disease. Postgrad Med J. 73:1997;549-552.
53. Chang K.H., Yi J.G., Han M.H., Kim I.O. MR imaging findings of moyamoya disease. J Korean Med Sci. 5:1990;85-90.
54. Houkin K., Tanaka N., Takahashi A., Kamiyama H., Abe H., Kajii N. Familial occurrence of moyamoya disease. Magnetic resonance angiography as a screening test for high-risk subjects. Childs Nerv Syst. 10:1994;421-425.